Showing results (3271-3280 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|December 6, 2025
Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping reviewGeorgia C Wright, Luke T Glover, Thomas J E HubbardBreast (Edinburgh, Scotland)|September 20, 2025
Artificial intelligence and radiomics biomarkers for treatment response prediction in advanced HER2-negative breast cancerLaurent Dercle, Jeremy McGale, Binsheng Zhao, et al.Breast (Edinburgh, Scotland)|August 13, 2025
Clinical and economic research of bone modifiers as adjuvant therapy for early breast cancer: A systematic literature reviewWenhua Wu, Yixiao Zhu, Huiting Lin, et al.Breast (Edinburgh, Scotland)|August 12, 2025
Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE studyT De La Motte Rouge, J-S Frenel, C Cropet, et al.Breast (Edinburgh, Scotland)|August 7, 2025
The association between breast fibrosis, cosmetic outcomes, and long-term health-related quality of life after breast-conserving therapy: a multicenter cross-sectional observational cohort studyM C A W Notenboom, T M A L Klem, C M E Contant, et al.Breast (Edinburgh, Scotland)|October 13, 2025
Overdiagnosis of ductal carcinoma in situ by grade and definition in population-based screening: A modeling studyKeris Poelhekken, Marcel J W Greuter, Bert van der Vegt, et al.Breast (Edinburgh, Scotland)|October 24, 2025
Postoperative radiation therapy in localized breast malignant phyllodes tumors: RPA-derived risk model identifies high-benefit subgroups with local control improvementWei-Hong Zheng, Zhi-Qing Long, Jia Kou, et al.Breast (Edinburgh, Scotland)|October 18, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancerKristien Borremans, Ha-Linh Nguyen, Maxim De Schepper, et al.Breast (Edinburgh, Scotland)|August 5, 2025
Central nervous system relapse in triple-negative breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy: A retrospective cohort analysisGabriel Berlingieri Polho, Yumi Ricucci Shinkado, Leticia Kimie Murazawa, et al.Breast (Edinburgh, Scotland)|August 6, 2025
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 studyLeandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, et al.Pageof 367